Literature DB >> 31594631

Ovarian stimulation and assisted reproductive technology outcomes in women transplanted with cryopreserved ovarian tissue: a systematic review.

Signe Taasti Andersen1, Susanne Elisabeth Pors1, Liv la Cour Poulsen2, Lotte Berdiin Colmorn3, Kirsten Tryde Macklon3, Erik Ernst4, Peter Humaidan5, Claus Yding Andersen1, Stine Gry Kristensen6.   

Abstract

OBJECTIVE: To systematically review reproductive outcomes of assisted reproductive technology (ART) treatment in women transplanted with frozen-thawed ovarian tissue.
DESIGN: Systematic review in accordance with guidelines from Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).
SETTING: Not applicable. PATIENT(S): Women undergoing ovarian tissue transplantation (OTT) and subsequent ART. INTERVENTION(S): Literature search in PubMed and Scopus databases. MAIN OUTCOME MEASURE(S): Time from OTT to initiation of ART, stimulation protocol, and conventional ART outcome measures. RESULT(S): Twenty studies (including 15 case reports), specifying ART treatments and outcomes of 40 women undergoing OTT were identified. Multiple stimulation protocols were applied, with the modified natural cycle as the most frequently used. In total, 195 ART cycles were performed (4.0 cycles per patient) resulting in 1.5 follicles and 1.0 mature oocyte retrieved per cycle. Empty follicle rates ranged from 23% to 35% in the three largest cohort studies. Twenty-five women (62.5%) had one or more pregnancies, of which 28.6% were lost, resulting in a total of 20 live births (22 children). Overall the pregnancy rates varied from 3.9% to 19.3% and live-birth rates from 3.9% to 14.0% per cycle in the three cohort studies. Fertility treatment was initiated shortly after OTT in some centers, while others awaited natural conception before embarking on ART treatment. CONCLUSION(S): The reported pregnancy and live-birth rates for women undergoing OTT and ART were considerably lower than those of the general in vitro fertilization (IVF) population, corresponding to patients with poor ovarian reserve. In general, ART outcomes are underreported, and there is a lack of consensus regarding the timing of ART in relation to OTT and the type of ovarian stimulation protocol.
Copyright © 2019 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ART; autotransplantation; live-birth rate; ovarian stimulation; ovarian tissue cryopreservation

Year:  2019        PMID: 31594631     DOI: 10.1016/j.fertnstert.2019.07.008

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  14 in total

Review 1.  Novel Approaches Used in Ovarian Tissue Transplantation for Fertility Preservation: Focus on Tissue Engineering Approaches and Angiogenesis Capacity.

Authors:  Melika Izadpanah; Reza Rahbarghazi; Abbas Majdi Seghinsara; Ali Abedelahi
Journal:  Reprod Sci       Date:  2022-08-12       Impact factor: 2.924

2.  Ovarian Tissue-Based Hormone Replacement Therapy Recovers Menopause-Related Signs in Mice.

Authors:  Dahyeon Yoo; Nanum Chung; Jungyoung Yoo; Chae Young Song; Chungmo Yang; Hye Won Youm; Kangwon Lee; Jin Hyun Jun; Jaewang Lee; Jung Ryeol Lee
Journal:  Yonsei Med J       Date:  2022-07       Impact factor: 3.052

3.  Fertility preservation strategies for cancerous women: An updated review.

Authors:  Fatemeh Anbari; Mohammad Ali Khalili; Maryam Mahaldashtian; Alireza Ahmadi; Maria Grazia Palmerini
Journal:  Turk J Obstet Gynecol       Date:  2022-06-27

4.  Ovarian tissue cryopreservation and novel bioengineering approaches for fertility preservation.

Authors:  Andrea S K Jones; Ariella Shikanov
Journal:  Curr Breast Cancer Rep       Date:  2020-11-04

5.  Oocyte cryopreservation versus ovarian tissue cryopreservation for adult female oncofertility patients: a cost-effectiveness study.

Authors:  Esther H Chung; Stephanie L Lim; Evan Myers; Haley A Moss; Kelly S Acharya
Journal:  J Assist Reprod Genet       Date:  2021-05-11       Impact factor: 3.357

Review 6.  Fertility preservation for young adults, adolescents, and children with cancer.

Authors:  Kenny A Rodriguez-Wallberg; Amandine Anastacio; Emelie Vonheim; Sandra Deen; Johan Malmros; Birgit Borgström
Journal:  Ups J Med Sci       Date:  2020-05-01       Impact factor: 2.384

7.  Efficacy of assisted reproductive technology after ovarian tissue transplantation in a cohort of 11 patients with or without associated infertility factors.

Authors:  M Vatel; A Torre; B Paillusson; F Scheffler; M Bergere; M Benkhalifa; M-T Le Martelot; F Leperlier; S Mirallié; L Selleret; M Prades-Borio; A Neuraz; V Barraud-Lange; N Boissel; A Fortin; C Poirot
Journal:  J Assist Reprod Genet       Date:  2021-01-03       Impact factor: 3.412

8.  Ovarian tissue grafting: Lessons learnt from our experience with 55 grafts.

Authors:  Genia Rozen; Stephanie Sii; Franca Agresta; Debra Gook; Alex Polyakov; Catharyn Stern
Journal:  Reprod Med Biol       Date:  2021-05-12

Review 9.  Gender-specific aspects related to type of fertility preservation strategies and access to fertility care.

Authors:  Marta Perachino; Claudia Massarotti; Maria Grazia Razeti; Francesca Parisi; Luca Arecco; Alessandra Damassi; Piero Fregatti; Cinzia Solinas; Matteo Lambertini
Journal:  ESMO Open       Date:  2020-10

10.  Pharmacological inhibition of the PI3K/PTEN/Akt and mTOR signalling pathways limits follicle activation induced by ovarian cryopreservation and in vitro culture.

Authors:  Carmen Terren; Michelle Nisolle; Carine Munaut
Journal:  J Ovarian Res       Date:  2021-07-19       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.